MEFLUVAC™ H9 ND-16

MEFLUVAC™ H9 ND-16 is an inactivated bivalent vaccine for immunization against Low Pathogenic Avian Influenza H9N2 subtype and Newcastle Disease. Target Species: Chickens.

Composition (before inactivation)

• Inactivated Low Pathogenic Avian Influenza H9N2 subtype belonging to G1-lineage:  [A/Chicken/Egypt/ME/543V/2016(H9N2)] ≥ 8.0 log₁₀ EID₅₀/dose.
• Newcastle Disease Virus LaSota strain: [(NDV/Chicken/Egypt/11478AF/2011)] ≥ 8.0 log₁₀ EID₅₀/dose.

Indications: Active immunization of commercial poultry against Low Pathogenic Avian Influenza H9N2 subtype and Newcastle Disease. Recommended Vaccination Program Birds can be vaccinated from seven days of age onwards, as per advice from your poultry veterinarian. For optimal booster effects, the birds should be primed with live NDV vaccines. Onset of immunity: 3 weeks after the first vaccination. Duration of immunity: conditioned to the vaccination scheme established for the local epidemiological situation. Administration

• Subcutaneous injection: in the lower part of the neck. The needle should be inserted just under the skin in a direction away from the head and in a straight line with the neck.
• Intramuscular injection: in the breast muscles by inserting the needle with a 45° angle to avoid intraperitoneal injection.

For optimal booster effects, the birds should be primed with live NDV vaccines. Dosage The vaccine dose (0.5 mL) should be administered in full to each bird.   MEFLUVAC™ H9 ND-16 is packed and presented in 500 mL (1000 doses)bottles.